Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism E2F1 inhibitors(Transcription factor E2F1 inhibitors), PGK1 inhibitors(phosphoglycerate kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 07 Nov 2025 | |
| Digestive System Disorders | Discovery | - | 07 Nov 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 07 Nov 2025 | |
| Neoplasms | Discovery | - | 07 Nov 2025 | |
| Osteoarthritis | Discovery | - | 07 Nov 2025 | |
| Other Diseases | Discovery | - | 07 Nov 2025 | |
| Pulmonary Fibrosis | Discovery | - | 07 Nov 2025 | |
| Urogenital Diseases | Discovery | - | 07 Nov 2025 |





